Information

We are a group of users focused on expanding the breadth and depth of Groovy and Grails development skills with our members who live and work in the DFW area. Our meetings are on the 1st Wednesday of every month (social & food at 6:30pm, meeting content at 7:00pm) at the NEW Improving office in Plano.

General Announcement

Starting with the June 2017 meeting we will be focusing on introducing new members to Groovy. We will have a series of talks that will bring them up to speed on Groovy, Gradle, Grails and application development. Please bring your friend, neighbor and co-worker, especially if they are familiar with Java, as the ramp-up is very easy.

Inside a world-first clinical trial conducted at Deakin School.

Old antibiotic could form new depression treatment An antibiotic used mainly to treat pimples continues to be found to boost the grade of life for those who have major depression, inside a world-first clinical trial conducted at Deakin School. The trial added a regular dosage of minocycline – a broad-spectrum antibiotic that is prescribed since 1971 – to the most common treatment of 71 people experiencing main depression. The extensive research team, led by Deakin’s Center for Innovation in Mental and Physical Health insurance and Clinical Treatment , then compared the consequences to a control group going for a placebo. The benefits – recently released in the Australian and New Zealand Journal of Psychiatry – demonstrated that those taking minocycline reported improved working and standard of living.Revlimid drives Celgene profit beat; raises EPS forecast – Celgene Corp rode its flagship multiple myeloma medication Revlimid and a rebound in product sales of Otezla for psoriasis to a modestly higher-than-expected second-quarter profit and raised its full-year earnings forecast about Thursday. But the lasting results didn’t win over Celgene and traders stocks, that are up about 17 % for the entire year, slipped 1 % to $136.40 following coming in contact with a two-year most of $139.